Company / Operating Income
Protara Therapeutics, Inc. Operating Income History
FY2014-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$7.6M
FY2016
5-year range
-$8.0M / -$7.1M
FY2014-FY2016
Trend
-6.4%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$8M to -$8M over the past 2 years.
Based on SEC 10-K filings.
-$8M in FY2016.
Improved from -$8M to -$8M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2016, operating income decreased 6.4% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.74 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2016 | -$7.6M | -6.4% |
| FY2015 | -$7.1M | +10.9% |
| FY2014 | -$8.0M | - |
As of FY2016 · SEC 10-K · Updated Jun 28, 2026